IL-21–Induced MHC Class II+NK Cells Promote the Expansion of Human Uncommitted CD4+Central Memory T Cells in a Macrophage Migration Inhibitory Factor–Dependent Manner
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-21–Induced MHC Class II+NK Cells Promote the Expansion of Human Uncommitted CD4+Central Memory T Cells in a Macrophage Migration Inhibitory Factor–Dependent Manner
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 1, Pages 85-96
Publisher
The American Association of Immunologists
Online
2016-05-28
DOI
10.4049/jimmunol.1501147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
- (2014) Ilona Kryczek et al. IMMUNITY
- Type 2 Innate Lymphoid Cells Drive CD4+ Th2 Cell Responses
- (2014) A. S. Mirchandani et al. JOURNAL OF IMMUNOLOGY
- Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses
- (2014) N. von Burg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Moving T memory stem cells to the clinic
- (2013) L. Gattinoni et al. BLOOD
- The who's who of T-cell differentiation: Human memory T-cell subsets
- (2013) Yolanda D. Mahnke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
- (2013) Stefanie Kirchberger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
- (2013) Matthew R. Hepworth et al. NATURE
- Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D
- (2013) B. Chaigne-Delalande et al. SCIENCE
- NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome
- (2013) S. Rusakiewicz et al. Science Translational Medicine
- Herpes Simplex Virus Antigens Directly Activate NK Cells via TLR2, Thus Facilitating Their Presentation to CD4 T Lymphocytes
- (2012) M. Kim et al. JOURNAL OF IMMUNOLOGY
- Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
- (2011) K. L. Hippen et al. BLOOD
- A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG
- (2011) J. Henry Evans et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
- (2010) Linda A. Lieberman et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46
- (2010) Maya Eisenring et al. NATURE IMMUNOLOGY
- IL-21 is critical for GVHD in a mouse model
- (2009) A Meguro et al. BONE MARROW TRANSPLANTATION
- Mechanism of Human Natural Killer Cell Activation byHaemophilus ducreyi
- (2009) Wei Li et al. JOURNAL OF INFECTIOUS DISEASES
- IL-21 Is Required to Control Chronic Viral Infection
- (2009) H. Elsaesser et al. SCIENCE
- Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis
- (2009) Marie Rubér et al. SURGERY
- IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis
- (2007) Ruolan Liu et al. EXPERIMENTAL NEUROLOGY
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started